跳至主要内容
临床试验/CTRI/2023/01/048665
CTRI/2023/01/048665尚未招募2 期

Pentoxifylline as adjunctive therapy in sepsis in preterm neonates: A double- blinded randomized controlled trial

Dr Deepak Chawla0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. New onset of at least two of the following signs after 12 hours of birth AND decision of the clinical care team to start or upgrade antibiotics:
  • -Temperature instability (hypothermia [ <36.5°C], hyperthermia [ >38°C], core- periphery temperature difference >2°C)
  • -Respiratory signs (tachypnea, grunting, intercostal/ subcostal retractions, apnea, cyanosis)
  • -Gastrointestinal signs (feeding intolerance, abdominal distension, altered aspirates, radiological signs)
  • -Neurologic signs (encephalopathy, hypotonia, lethargy, seizures)
  • -Unexplained metabolic acidosis (BE > -10)
  • -Hypoglycemia ( <45 mg/dl) or hyperglycemia ( >140 mg/dl)
  • â?? Increased oxygen requirement or ventilatory support
  • 2. Any one of the following AND decision of the clinical care team to start or upgrade antibiotics:
  • -Shock needing inotropic support
  • -Positive blood or CSF culture

排除标准

  • Neonates with any of the following conditions will be excluded
  • IVH (grade 3 or 4)
  • Major congenital malformation

研究者

发起方
Dr Deepak Chawla

相似试验